{"id":"https://openalex.org/W4290771807","doi":"https://doi.org/10.1097/md.0000000000029473","title":"Immune-checkpoint inhibitor-associated grade 3 hepatotoxicity managed with enteric-coated budesonide monotherapy: A case report","display_name":"Immune-checkpoint inhibitor-associated grade 3 hepatotoxicity managed with enteric-coated budesonide monotherapy: A case report","publication_year":2022,"publication_date":"2022-08-05","ids":{"openalex":"https://openalex.org/W4290771807","doi":"https://doi.org/10.1097/md.0000000000029473","pmid":"https://pubmed.ncbi.nlm.nih.gov/35945730","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9351916"},"language":"en","primary_location":{"id":"doi:10.1097/md.0000000000029473","doi":"https://doi.org/10.1097/md.0000000000029473","is_oa":true,"landing_page_url":"https://doi.org/10.1097/md.0000000000029473","pdf_url":null,"source":{"id":"https://openalex.org/S28966261","display_name":"Medicine","issn_l":"0025-7974","issn":["0025-7974","1536-5964"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4290771807"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1097/md.0000000000029473","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081860359","display_name":"Gerasimos Eleftheriotis","orcid":"https://orcid.org/0000-0003-3665-2855","observed_orcids":["https://orcid.org/0000-0003-3665-2855"]},"institutions":[{"id":"https://openalex.org/I4210140769","display_name":"General Hospital of Nikea","ror":"https://ror.org/043eknq26","country_code":"GR","type":"healthcare","lineage":["https://openalex.org/I4210140769"]}],"countries":["GR"],"is_corresponding":true,"raw_author_name":"Gerasimos Eleftheriotis","raw_affiliation_strings":["2nd Department of Internal Medicine, General Hospital of Nikaia-Piraeus \u201cAgios Panteleimon,\u201d Athens, Greece"],"raw_orcid":"https://orcid.org/0000-0003-3665-2855","affiliations":[{"raw_affiliation_string":"2nd Department of Internal Medicine, General Hospital of Nikaia-Piraeus \u201cAgios Panteleimon,\u201d Athens, Greece","institution_ids":["https://openalex.org/I4210140769"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037606388","display_name":"Elias E. Skopelitis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140769","display_name":"General Hospital of Nikea","ror":"https://ror.org/043eknq26","country_code":"GR","type":"healthcare","lineage":["https://openalex.org/I4210140769"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Elias Skopelitis","raw_affiliation_strings":["2nd Department of Internal Medicine, General Hospital of Nikaia-Piraeus \u201cAgios Panteleimon,\u201d Athens, Greece","101:31(e29473)","Data sharing not applicable to this article as no datasets were generated or analyzed during the current study","How to cite this article: Eleftheriotis G, Skopelitis E. Immune-checkpoint inhibitor-associated grade 3 hepatotoxicity managed with enteric-coated budesonide monotherapy: A case report. Medicine 2022","Written informed consent was obtained from the patient for publication of this case report"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2nd Department of Internal Medicine, General Hospital of Nikaia-Piraeus \u201cAgios Panteleimon,\u201d Athens, Greece","institution_ids":["https://openalex.org/I4210140769"]},{"raw_affiliation_string":"101:31(e29473)","institution_ids":[]},{"raw_affiliation_string":"Data sharing not applicable to this article as no datasets were generated or analyzed during the current study","institution_ids":[]},{"raw_affiliation_string":"How to cite this article: Eleftheriotis G, Skopelitis E. Immune-checkpoint inhibitor-associated grade 3 hepatotoxicity managed with enteric-coated budesonide monotherapy: A case report. Medicine 2022","institution_ids":[]},{"raw_affiliation_string":"Written informed consent was obtained from the patient for publication of this case report","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5081860359"],"corresponding_institution_ids":["https://openalex.org/I4210140769"],"apc_list":{"value":1950,"currency":"USD","value_usd":1950},"apc_paid":{"value":1950,"currency":"USD","value_usd":1950},"fwci":1.3285,"has_fulltext":true,"cited_by_count":15,"citation_normalized_percentile":{"value":0.80982203,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"101","issue":"31","first_page":"e29473","last_page":"e29473"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.010999999940395355,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8450000286102295},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.8930000066757202},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.8769999742507935},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.8339999914169312},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.8379999995231628},{"id":"https://openalex.org/keywords/aminotransferase-elevation","display_name":"aminotransferase elevation","score":0.8109999895095825},{"id":"https://openalex.org/keywords/corticosteroid-monotherapy","display_name":"corticosteroid monotherapy","score":0.824999988079071},{"id":"https://openalex.org/keywords/immunotherapy-rechallenge","display_name":"immunotherapy rechallenge","score":0.9210000038146973},{"id":"https://openalex.org/keywords/dose-tapering","display_name":"dose tapering","score":0.781000018119812},{"id":"https://openalex.org/keywords/hepatic-first-pass-metabolism","display_name":"hepatic first-pass metabolism","score":0.7590000033378601}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9622368812561035},{"id":"https://openalex.org/C2776136866","wikidata":"https://www.wikidata.org/wiki/Q422212","display_name":"Budesonide","level":3,"score":0.8651610612869263},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6691663861274719},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.5944006443023682},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.5433500409126282},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5349600911140442},{"id":"https://openalex.org/C2780252810","wikidata":"https://www.wikidata.org/wiki/Q1455316","display_name":"Immunosuppression","level":2,"score":0.5297751426696777},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5295981764793396},{"id":"https://openalex.org/C2776804153","wikidata":"https://www.wikidata.org/wiki/Q210420","display_name":"Corticosteroid","level":2,"score":0.5079267621040344},{"id":"https://openalex.org/C2776715498","wikidata":"https://www.wikidata.org/wiki/Q11426176","display_name":"Prednisolone","level":2,"score":0.46717506647109985},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.4294658303260803},{"id":"https://openalex.org/C2779802037","wikidata":"https://www.wikidata.org/wiki/Q40878","display_name":"Diarrhea","level":2,"score":0.41454583406448364},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.24603590369224548},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.1320803463459015}],"mesh":[{"descriptor_ui":"D000074324","descriptor_name":"Ipilimumab","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000637","descriptor_name":"Transaminases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008224","descriptor_name":"Lymphoma, Follicular","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D019819","descriptor_name":"Budesonide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D056486","descriptor_name":"Chemical and Drug Induced Liver Injury","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D056486","descriptor_name":"Chemical and Drug Induced Liver Injury","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1097/md.0000000000029473","doi":"https://doi.org/10.1097/md.0000000000029473","is_oa":true,"landing_page_url":"https://doi.org/10.1097/md.0000000000029473","pdf_url":null,"source":{"id":"https://openalex.org/S28966261","display_name":"Medicine","issn_l":"0025-7974","issn":["0025-7974","1536-5964"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicine","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9351916","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9351916/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9351916/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicine (Baltimore)","raw_type":"Text"},{"id":"pmid:35945730","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35945730","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicine","raw_type":"Case Reports"}],"best_oa_location":{"id":"doi:10.1097/md.0000000000029473","doi":"https://doi.org/10.1097/md.0000000000029473","is_oa":true,"landing_page_url":"https://doi.org/10.1097/md.0000000000029473","pdf_url":null,"source":{"id":"https://openalex.org/S28966261","display_name":"Medicine","issn_l":"0025-7974","issn":["0025-7974","1536-5964"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4290771807.pdf","grobid_xml":"https://content.openalex.org/works/W4290771807.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W1986690646","https://openalex.org/W2015411480","https://openalex.org/W2027812459","https://openalex.org/W2074557796","https://openalex.org/W2095262005","https://openalex.org/W2111273085","https://openalex.org/W2152194859","https://openalex.org/W2164918836","https://openalex.org/W2291096806","https://openalex.org/W2342066803","https://openalex.org/W2539887947","https://openalex.org/W2559625219","https://openalex.org/W2600347335","https://openalex.org/W2624661718","https://openalex.org/W2736166064","https://openalex.org/W2753432434","https://openalex.org/W2760893760","https://openalex.org/W2786816161","https://openalex.org/W2788726176","https://openalex.org/W2789465456","https://openalex.org/W2888298425","https://openalex.org/W2902644090","https://openalex.org/W2925446385","https://openalex.org/W2987833617","https://openalex.org/W2995815973","https://openalex.org/W3092023433","https://openalex.org/W3092802874","https://openalex.org/W3135254573","https://openalex.org/W6889120927"],"related_works":["https://openalex.org/W4327855667","https://openalex.org/W4387752052","https://openalex.org/W4406633127","https://openalex.org/W3211055028","https://openalex.org/W2891820518","https://openalex.org/W4403721126","https://openalex.org/W3210458908","https://openalex.org/W4281386300","https://openalex.org/W2939863421","https://openalex.org/W3199659450"],"abstract_inverted_index":{"RATIONALE:":[0],"The":[1,142],"introduction":[2],"of":[3,15,34,93,148,176,190,214,241,261],"immune-checkpoint":[4],"inhibitors":[5],"(ICPI)":[6],"in":[7,57,223,245,265,272,283,286],"recent":[8],"years":[9],"has":[10,47],"changed":[11],"the":[12,86,120,136,173,187,221,224,239,258,284],"natural":[13],"course":[14],"many":[16],"neoplasms.":[17],"However,":[18],"patients":[19,267],"receiving":[20],"these":[21,292],"medications":[22],"may":[23,232],"present":[24],"immune-mediated":[25],"adverse":[26,49],"events;":[27],"management":[28,240],"includes":[29],"temporary":[30],"or":[31,208,290],"permanent":[32],"cessation":[33],"treatment":[35,249],"and":[36,51,88,115,131,257],"corticosteroids,":[37],"occasionally":[38],"combined":[39],"with":[40,105,111,153,205,227],"other":[41],"immunomodulators.":[42],"Such":[43],"immunosuppression,":[44],"however,":[45],"also":[46,138],"numerous":[48],"events":[50],"even":[52],"if":[53],"it":[54,60],"is":[55,79,250],"effective":[56],"controlling":[58],"toxicity,":[59],"delays":[61],"immunotherapy":[62,263],"reinitiation,":[63],"as":[64,90],"current":[65],"evidence":[66],"requires":[67],"dose":[68,165,175,189,196,270],"tapering":[69],"to":[70,85,180,218,253,274,288],"\u226410":[71],"mg":[72,201],"prednisolone":[73],"equivalent":[74],"before":[75],"rechallenge.":[76],"Enteric-coated":[77],"budesonide":[78,228,231],"a":[80,91,234],"corticosteroid":[81,248],"formulation":[82],"acting":[83,276],"primarily":[84],"intestine":[87],"liver,":[89],"result":[92],"its":[94,254],"extensive":[95],"first-pass":[96],"hepatic":[97],"metabolism.":[98],"PATIENT":[99],"CONCERNS:":[100],"A":[101],"76-year-old":[102],"woman":[103],"treated":[104],"ipilimumab":[106],"for":[107,117,238],"metastatic":[108],"melanoma":[109],"presented":[110],"abdominal":[112],"pain,":[113],"vomiting,":[114],"diarrhea":[116],"at":[118],"least":[119],"previous":[121],"4":[122],"days.":[123],"Laboratory":[124],"tests,":[125],"among":[126],"others,":[127],"revealed":[128],"elevated":[129],"aminotransferases":[130],"C-reactive":[132],"protein.":[133],"During":[134],"hospitalization,":[135],"patient":[137],"developed":[139],"fever.":[140],"DIAGNOSIS:":[141],"patient,":[143],"after":[144,172,186],"excluding":[145],"alternative":[146],"causes":[147],"aminotransferase":[149],"elevation,":[150],"was":[151,161,166,197],"diagnosed":[152],"grade":[154],"3":[155,200],"ipilimumab-associated":[156],"hepatotoxicity.":[157],"INTERVENTIONS:":[158],"Budesonide":[159],"monotherapy":[160],"administered;":[162],"initial":[163],"daily":[164,195],"12":[167],"mg.":[168],"OUTCOMES:":[169],"Fever":[170],"subsided":[171],"first":[174,188,222],"budesonide.":[177,191],"Aminotransferases":[178],"returned":[179],"normal-near":[181],"normal":[182],"approximately":[183],"1":[184],"month":[185],"After":[192],"this":[193],"point,":[194],"reduced":[198],"by":[199],"every":[202],"2":[203],"weeks,":[204],"no":[206],"clinical":[207],"biochemical":[209],"relapse.":[210],"CONCLUSIONS:":[211],"This":[212],"case":[213],"ICPI":[215],"hepatitis":[216],"is,":[217],"our":[219],"knowledge,":[220],"literature":[225],"managed":[226],"monotherapy.":[229],"Therefore,":[230],"be":[233,281],"potentially":[235],"attractive":[236],"option":[237],"ICPI-associated":[242],"liver":[243],"injury":[244],"cases":[246],"where":[247],"necessary":[251],"due":[252],"safety":[255],"profile":[256],"potential":[259],"advantage":[260],"faster":[262],"rechallenge":[264],"selected":[266],"without":[268],"requiring":[269],"tapering,":[271],"contrast":[273],"systemically":[275],"corticosteroids.":[277],"Clinical":[278],"trials":[279],"should":[280],"conducted":[282],"future":[285],"order":[287],"validate":[289],"refute":[291],"findings.":[293]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":6},{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2022-08-09T00:00:00"}